MedXY – Page 23

Fetal Growth Restriction and Risk of Superimposed Preeclampsia in Women with Chronic Hypertension: Implications for Clinical Surveillance

By MedXY 09/05/2026

In women with chronic hypertension, fetal growth restriction at 35-36 weeks gestation predicts higher progression to superimposed preeclampsia, underscoring the need for targeted maternal-fetal surveillance.

Infectious Diseases news OB/GYN & Women's Health

Intra-amniotic Categories of Preterm Prelabor Rupture of Membranes: Gestational Age-Specific Distribution, Amniotic Fluid Microbial Profiles, and Neonatal Outcomes

By MedXY 09/05/2026

This study classifies preterm prelabor rupture of membranes (PROM) into four intra-amniotic types, detailing differences in gestational age distribution, microbial profiles, and neonatal outcomes, highlighting risks associated with infections beyond Ureaplasma spp.

news OB/GYN & Women's Health

Enhancing Sexual and Pelvic Health in Women: Efficacy of Scheduled Vibrator Use in a Randomized Controlled Trial

By MedXY 09/05/2026

Scheduled vibrator use combined with educational support significantly improves sexual function in women with sexual dysfunction and pelvic floor disorders compared to education alone.

news OB/GYN & Women's Health Public Health

Updated Federal Regulation: How the Pregnant Workers Fairness Act (PWFA) Changes Care and Counseling in Obstetrics

By MedXY 09/05/2026

This article summarizes ACOG’s 2026 Committee Statement on the Pregnant Workers Fairness Act, explains clinician roles in documentation and accommodation, and outlines practical recommendations for obstetric care.

Gastroenterology news Oncology

Decoding CPEB3-Regulated Alternative Polyadenylation: A New Genetic Lens on Hepatocellular Carcinoma Prognosis

By MedXY 09/05/2026

This article explores how genetic variants affect CPEB3-mediated alternative polyadenylation in hepatocellular carcinoma, revealing potential prognostic markers and therapeutic targets to improve patient survival.

Gastroenterology news Oncology

Achalasia and Its Differential Impact on Esophageal Squamous Cell Carcinoma and Adenocarcinoma Risk: Insights from a Large Nordic Case-Control Study

By MedXY 09/05/2026

A comprehensive multinational study reveals that achalasia significantly raises the risk of esophageal squamous cell carcinoma independently, while its association with adenocarcinoma is modest and largely mediated by gastroesophageal reflux disease.

Gastroenterology news

Confocal Laser Endomicroscopy-Guided Exclusion Diet Fails to Improve IBS Symptoms in Controlled Trial

By MedXY 09/05/2026

A randomized controlled crossover trial found that individualized exclusion diets based on confocal laser endomicroscopy (CLE) findings do not significantly improve symptoms in irritable bowel syndrome (IBS) patients compared to sham diets. Moreover, CLE-detected mucosal alterations are non-specific and present in healthy individuals.

Neurology news

BCKDK: Unlocking a New Hypoxia-Sensitive Target to Mitigate Cerebral Ischemic Injury

By MedXY 09/05/2026

This article details how BCKDK, a hypoxia-induced kinase, disrupts branched-chain amino acid metabolism to worsen neuronal injury in cerebral ischemia, highlighting its potential as a novel therapeutic target.

Neurology news

Unraveling the Link Between Alzheimer’s Pathology, Sleep Disturbances, and Cognitive Decline in Late-Onset Unexplained Epilepsy

By MedXY 09/05/2026

Elevated plasma p-tau217 correlates with cognitive impairment and altered sleep microarchitecture in older adults with late-onset unexplained epilepsy, highlighting potential pathways linking neurodegeneration, epilepsy severity, and sleep disruptions.

Neurology news

Unraveling Alzheimer’s Disease Progression in Down Syndrome via Blood Proteome Dynamics

By MedXY 09/05/2026

Longitudinal analysis of blood proteins reveals distinctive trajectories and associations with cognitive decline in adults with Down syndrome, shedding light on Alzheimer's disease pathophysiology in this high-risk group.

Neurology news

Evaluating Tirofiban Plus Aspirin in Branch Atheromatous Disease Stroke: Insights from the STRATEGY Trial

By MedXY 09/05/2026

The STRATEGY trial assessed whether combining tirofiban with aspirin improves outcomes in branch atheromatous disease (BAD)-related stroke but found no significant benefit over aspirin alone in preventing neurological deterioration or recurrent stroke.

Clinical Updates Neurology news Pediatrics

Safety and Efficacy of Guanabenz in Early-Childhood Onset Vanishing White Matter: Insights from a Phase 1/2 Single-Arm Trial

By MedXY 09/05/2026

This review synthesizes recent evidence demonstrating guanabenz's manageable safety profile and efficacy in delaying ambulatory decline in early-onset vanishing white matter disease, highlighting translational pharmacokinetic data and clinical outcomes.

Neurology news OB/GYN & Women's Health

Antiseizure Medication Use During Pregnancy: Implications for Fetal Growth from the EURAP Registry

By MedXY 09/05/2026

A comprehensive cohort study from the EURAP registry reveals that antiseizure medication, especially polytherapy and certain monotherapies, increases the risk of poor fetal growth, underscoring the need for optimized treatment strategies during pregnancy.

Diabetes & Endocrinology news Oncology

Levothyroxine-Induced Mild TSH Suppression Elevates Reverse T3 without Altering fT3 in Euthyroid Papillary Thyroid Microcarcinoma Patients on Active Surveillance

By MedXY 09/05/2026

Levothyroxine therapy lowering TSH in euthyroid PTMC patients during active surveillance raises reverse T3 levels while maintaining stable free T3, suggesting altered thyroid hormone metabolism and a compensatory adaptive response.

Allergy & Immunology Diabetes & Endocrinology news

Unraveling Genetic Pathways in Type 1 Diabetes: Distinct HLA-DR3 and DR4 Effects on Disease Progression

By MedXY 09/05/2026

This study reveals that genetic risk factors and immune pathways differ significantly between type 1 diabetes patients stratified by HLA-DR3 and HLA-DR4 status, providing insights into disease heterogeneity and personalized risk mechanisms.

Diabetes & Endocrinology news

Decoding Pancreatic Islet Single-Cell Transcriptomic Diversity Across Type 2 Diabetes Subtypes

By MedXY 09/04/2026

Single-cell RNA sequencing of pancreatic islets reveals distinct molecular signatures linked to specific clinical subtypes of type 2 diabetes, highlighting the heterogeneous pathophysiology and providing potential subtype-specific therapeutic targets.

Diabetes & Endocrinology news Pediatrics

Impact of Elexacaftor/Tezacaftor/Ivacaftor Therapy on Glucose Metabolism in Youths with Cystic Fibrosis: Insights from Continuous Glucose Monitoring

By MedXY 09/04/2026

This study demonstrates that initiation of elexacaftor/tezacaftor/ivacaftor (ETI) therapy in children and adolescents with cystic fibrosis improves continuous glucose monitoring (CGM) metrics, correlating with better clinical outcomes.

Diabetes & Endocrinology news Oncology

Approach to the Patient: Theranostics as Precision Medicine for Neuroendocrine Tumors

By MedXY 09/04/2026

Presentation of three neuroendocrine tumor cases illustrating theranostics integration in diagnosis, treatment, and management, highlighting receptor-based imaging and personalized radionuclide therapy.

Diabetes & Endocrinology news Orthopedics

Charcot Neuro-Osteoarthropathy in Diabetes: High Risk of Hospitalization, Amputation, and Mortality Revealed by Regional Cohort Study

By MedXY 09/04/2026

Charcot neuro-osteoarthropathy (CNO) in people with diabetes is linked to frequent emergency hospitalizations, substantial risk of limb amputation, and reduced survival, highlighting urgent need for intensified multidisciplinary care.